Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with Systemic Lupus Erythematosus (SLE)

Clinical Rheumatology

Volumn 32, Issue 7, 2013, Pages 1045-1052

  Mengya, Zhu ^a   Hanyou, Mo ^a   Dong, Li ^a   Xiaohong, Luo ^a   Lihua, Zhang ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Regulatory T cells; Systemic Lupus Erythematosus; T helper cell 17

Indexed keywords

CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANGIOGRAPHY; ATHEROSCLEROSIS; CELL FUNCTION; CELL MIGRATION; CHOLESTEROL BLOOD LEVEL; CLINICAL OBSERVATION; COLOR ULTRASOUND FLOWMETRY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND;

ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY, DOPPLER; YOUNG ADULT;

EID: 84880173451     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2237-z     Document Type: Conference Paper

References (23)

1. Von Feldt JM (2008) Premature atherosclerotic cardiovascular disease and Systemic Lupus Erythematosus from bedside to bench. Bull NYU Hosp Jt Dis 66:184-187
2. Boucelma M, Haddoum F, Chaudet H et al (2011) Cardiovascular risk and lupus disease. Int Angiol 30:18-24
3. Sherer Y, Zinger H, Shoenfeld Y (2010) Atherosclerosis in Systemic Lupus Erythematosus. Autoimmunity 43:98-102
4. Koltsova EK, Garcia Z, Chodaczek G et al (2012) Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis. J Clin Invest 122:3114-26
5. Frieri M (2012) Accelerated atherosclerosis in Systemic Lupus Erythematosus: role of proinflammatory cytokines and therapeutic approaches. Curr Allergy Asthma Rep 12:25-32
6. Scalapino KJ, Tang QB, Luestone JA et al (2006) Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 177:1451-1459 (Pubitemid 44092478)
7. Puddu PE, Lanti M, Menotti A et al (2001) Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population study. Acta Cardiol 56:243-251 (Pubitemid 32848607)
8. Sato H, Miida T, Wada Y (2007) Atherosclerosis is accelerated in patients with long-term well-controlled Systemic Lupus Erythematosus (SLE). Clin Chim Acta 385:35-42 (Pubitemid 47376930)
9. Barta Z, Harrison MJ, Wangrangsimakul T et al (2010) Health-related quality of life, smoking and carotid atherosclerosis in white British women with Systemic Lupus Erythematosus. Lupus 19:231-238
10. Wade NS, Major AS (2011) The problem of accelerated atherosclerosis in Systemic Lupus Erythematosus: insights into a complex co-morbidity. Thromb Haemost 106:849-57
11. Petri MA, Kiani AN, Post W et al (2011) Lupus Atherosclerosis Prevention Study (LAPS). Ann Rheum Dis 70:760-765
12. Kiani AN, Post WS, Magder LS et al (2011) Predictors of progression in atherosclerosis over 2 years in Systemic Lupus Erythematosus. Rheumatology (Oxford) 50:2071-2079
13. Sakaguchi S (2005) Naturally arising Foxp3 expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 699:345-352 (Pubitemid 41716771)
14. Komiyama Y, Nakae S, Matsuki T et al (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177:566-573 (Pubitemid 43939170)
15. Okamoto A, Fujio K, Okamura T et al (2011) Regulatory T-cell-associated cytokines in Systemic Lupus Erythematosus. J Biomed Biotechnol 463412
16. Chaudhry A, Samstein RM, Treuting P et al (2011) Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34:566-578
17. Zheng Y, Danilenko DM, Valdez P et al (2006) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648-651 (Pubitemid 46232884)
18. Romagnani S, Maggi E, Liotta F et al (2009) Properties and origin of human Th17 cells. Mol Immunol 47:3-7
19. Xing Q, Wang B, Su H et al (2012) Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol Int 32:949-958
20. Robinson DS (2009) Regulatory T cells and asthma. Clin Exp Allergy 39:1314-23
21. Gotsman I, Grabie N, Gupta R et al (2006) Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 114:2047-2055 (Pubitemid 44706881)
22. Tu H, Li Q, Xiang S et al (2012) Dual effects of statins therapy in Systemic Lupus Erythematosus and SLE-related atherosclerosis: the potential role for regulatory T cells. Atherosclerosis 222:29-33
23. Svenungsson E, Fei GZ, Jensen-Urstad K et al (2003) TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease. Lupus 12:454-61 (Pubitemid 36830119)